Establishment and characterization of six human lung cancer cell lines: EGFR, p53 gene mutations and expressions of drug sensitivity genes. (Q52834190)

8 May 2018

title

Establishment and characterization of six human lung cancer cell lines: EGFR, p53 gene mutations and expressions of drug sensitivity genes. (English)

1 reference

8 May 2018

0 references

8

Yung-Jue Bang

1 reference

8 May 2018

Tae-You Kim

7

object named as

Tae-You Kim

1 reference

8 May 2018

Jae-Gahb Park

10

object named as

Jae-Gahb Park

1 reference

8 May 2018

Ja-Lok Ku

1

object named as

Ja-Lok Ku

1 reference

8 May 2018

author name string

Kyung-Hee Kim

2

1 reference

8 May 2018

Jin-Sung Choi

3

1 reference

8 May 2018

You-Kyung Jeon

4

1 reference

8 May 2018

Sung-Hee Kim

5

1 reference

8 May 2018

Young-Kyoung Shin

6

1 reference

8 May 2018

Woo Ho Kim

9

1 reference

8 May 2018

publication date

2 February 2011

1 reference

8 May 2018

published in

Cellular Oncology

1 reference

8 May 2018

volume

34

1 reference

8 May 2018

issue

1

1 reference

8 May 2018

page(s)

45-54

1 reference

8 May 2018

describes a project that uses

0 references

0 references

0 references

0 references

0 references

0 references

Cancer statistics, 2008

1 reference

https://api.crossref.org/works/10.1007%2FS13402-010-0004-6

Dissecting the genetic alterations involved in lung carcinogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13402-010-0004-6

Distinctive activation patterns in constitutively active and gefitinib-sensitive EGFR mutants

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13402-010-0004-6

Predictive and prognostic impact of epidermal growth factor receptor mutation in non-small-cell lung cancer patients treated with gefitinib

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13402-010-0004-6

Establishment and characterization of four human pancreatic carcinoma cell lines. Genetic alterations in the TGFBR2 gene but not in the MADH4 gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13402-010-0004-6

Establishment and characterization of cell lines from three human thyroid carcinomas: responses to all-trans-retinoic acid and mutations in the BRAF gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13402-010-0004-6

Mutation of p53 gene in hepatocellular carcinoma cell lines with HBX DNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13402-010-0004-6

BCRP/MXR/ABCP expression in topotecan-resistant human breast carcinoma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13402-010-0004-6

p53 mutations in human cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13402-010-0004-6

The codon 72 polymorphic variants of p53 have markedly different apoptotic potential

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13402-010-0004-6

Different subtypes of human lung adenocarcinoma caused by different etiological factors. Evidence from p53 mutational spectra

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13402-010-0004-6

Etiologic value of p53 mutation spectra and differences with histology in lung cancers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13402-010-0004-6

Inactivation of the transforming growth factor beta type II receptor in human small cell lung cancer cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13402-010-0004-6

Correlation between cyclooxygenase-2 and tumor angiogenesis in non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13402-010-0004-6

MDR1 gene expression: its effect on drug resistance to doxorubicin in human hepatocellular carcinoma cell lines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13402-010-0004-6

Single amino acid substitutions in the transmembrane domains of breast cancer resistance protein (BCRP) alter cross resistance patterns in transfectants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13402-010-0004-6

Gene expression profiling of epidermal growth factor receptor/KRAS pathway activation in lung adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13402-010-0004-6

High frequency of epidermal growth factor receptor mutations with complex patterns in non-small cell lung cancers related to gefitinib responsiveness in Taiwan

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13402-010-0004-6

Chromogranin A gene expression in non-small cell lung carcinomas

21 January 2018

1 reference

12 December 2020

The relationship between epidermal growth factor receptor mutations and clinicopathologic features in non-small cell lung cancers

1 reference

12 December 2020

Re: Growth of cell lines and clinical specimens of human non-small cell lung cancer in a serum-free defined medium

1 reference

12 December 2020

Genomic structure of the transforming growth factor beta type II receptor gene and its mutations in hereditary nonpolyposis colorectal cancers

1 reference

12 December 2020

Cell culture methods for human lung cancer

1 reference

12 December 2020

Activation of the beta-catenin gene by interstitial deletions involving exon 3 in primary colorectal carcinomas without adenomatous polyposis coli mutations

1 reference

12 December 2020

Differential effects of the breast cancer resistance protein on the cellular accumulation and cytotoxicity of 9-aminocamptothecin and 9-nitrocamptothecin

1 reference

12 December 2020

Mutations in beta-catenin are uncommon in colorectal cancer occurring in occasional replication error-positive tumors

1 reference

12 December 2020

β‐Catenin mutations in pulmonary blastomas: association with morule formation

1 reference

12 December 2020

p53 codon 72 polymorphism as a risk factor in the development of breast cancer

1 reference

12 December 2020

p53 mutational spectra are different between squamous-cell carcinomas of the lip and the oral cavity

1 reference

12 December 2020

Characterization and authentication of cancer cell lines: an overview.

1 reference

12 December 2020

Neuroendocrine marker expression in cervical carcinomas of non-small cell type

1 reference

12 December 2020

Cyclooxygenase-1 and -2 in human testicular tumours

1 reference

12 December 2020

Hypermethylation of E-cadherin in leukemia

1 reference

12 December 2020

2002 annual report of the Korea Central Cancer Registry: based on registered data from 139 hospitals

1 reference

12 December 2020

All-trans-retinoic acid modulates expression levels of thyroglobulin and cytokines in a new human poorly differentiated papillary thyroid carcinoma cell line, KTC-1.

1 reference

12 December 2020

10.1007/S13402-010-0004-6

Identifiers

DOI

1 reference

8 May 2018

1 reference

8 May 2018